Formation and reactivity of alternative quinone methides from butylated hydroxytoluene: possible explanation for species-specific pneumotoxicity
- 1 January 1990
- journal article
- research article
- Published by American Chemical Society (ACS) in Chemical Research in Toxicology
- Vol. 3 (1) , 65-70
- https://doi.org/10.1021/tx00013a011
Abstract
Previous work has shown that butylated hydroxytoluene [2,6-di-tert-butyl-4-methylphenol (BHT)] undergoes .pi.-oxidation in liver microsomes to form the quinone methide 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone (QM). This electrophilic species binds covalently to glutathione and protein thiols and is believed to initiate pulmonary toxicity in mice. In the present investigation, we identified another quinone methide metabolite of BHT, 6-tert-butyl-2-(hydroxy-tert-butyl)-4-methylene-2,5-cyclohexadienone (QM-OH), formed subsequent to the microsomal hydroxylation of BHT at a tert-butyl group. Mouse liver and lung microsomes generate the two quinone methides, and evidence was obtained that both metabolites also are formed in vivo. In contrast, rat microsomes produce QM almost exclusively, with only traces of QM-OH formed in liver and none in lung. Studies of the chemical reactivities of the two quinone methides with GSH demonstrated that QM-OH reacts about 6-fold faster than QM. Infrared spectra, 1H NMR spectra, and electrochemical measurements all support the proposal that the enhanced electrophilicity of QM-OH is due to intramolecular hydrogen bonding of the ring oxygen with the side-chain hydroxyl. The results provide evidence, therefore, that the previous metabolic scheme for bioactivation of BHT to a pulmonary toxin should be amended to include tert-butyl hydroxylation and subsequent .pi.-oxidation to the activated electrophile QM-OH. This scheme is consistent with published data concerning BHT-induced pulmonary toxicity and provides as explanation for the species specificity of this effect.This publication has 17 references indexed in Scilit:
- Isotope effects on the metabolism and pulmonary toxicity of butylated hydroxytoluene in mice by deuteration of the 4-methyl groupToxicology and Applied Pharmacology, 1983
- On the mechanism of covalent binding of butylated hydroxytoluene to microsomal proteinBiochemical Pharmacology, 1983
- Identification and determination of glutathione and glucuronide conjugates formed from butylated hydroxytoluene in rats.CHEMICAL & PHARMACEUTICAL BULLETIN, 1983
- Pulmonary toxicity of butylated hydroxytoluene and related alkylphenols: Structural requirements for toxic potency in mice*1Toxicology and Applied Pharmacology, 1982
- Biotransformation of butylated hydroxytoluene (BHT) to BHT-quinone methide in rats.CHEMICAL & PHARMACEUTICAL BULLETIN, 1981
- Effects of drug metabolism inhibitors on butylated hydroxytoluene-induced pulmonary toxicity in miceToxicology and Applied Pharmacology, 1980
- 2,6-di-tert-butyl-4- methylene-2,5-cyclohexadienone: A hepatic metabolite of butylated hydroxytoluene in ratsFood and Cosmetics Toxicology, 1979
- Biological fate of butylated hydroxytoluene (BHT); Binding in vivo of BHT to macromolecules of rat liver.CHEMICAL & PHARMACEUTICAL BULLETIN, 1979
- Dose-response study of hemorrhagic death by dietary butylated hydroxytoluene (BHT) in male ratsToxicology and Applied Pharmacology, 1978
- Enhancement of Urethan Tumorigenesis in Mouse Lung by Butylated Hydroxytoluene2JNCI Journal of the National Cancer Institute, 1977